The Dextrose and Potassium Chloride, cataloged under National Stock Number 6505-01-180-6945, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Baxter Healthcare Corp IV Systems/gov Sales. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-180-6945 |
| Primary Part Number | 2B1264 |
| Item Name | Dextrose and Potassium Chloride |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Baxter Healthcare Corp IV Systems/gov Sales |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 1000.000 MILLILITERS |
| Primary Container Type | BAG, PLASTIC |
| Active Medicament Medicinal Strength | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 40.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| 2B1264 PRIMARY | Baxter Healthcare Corp IV Systems/gov Sales (USA) |
| NDC00338-0687-04 PRIMARY | Baxter Healthcare Corp IV Systems/gov Sales (USA) |
NSN 6505-01-180-6945 is a Dextrose and Potassium Chloride, manufactured by Baxter Healthcare Corp IV Systems/gov Sales, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-180-6945 has 2 manufacturer part numbers on file: 2B1264 (Baxter Healthcare Corp IV Systems/gov Sales), NDC00338-0687-04 (Baxter Healthcare Corp IV Systems/gov Sales).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-462-4785. Verify interchangeability with system specifications before substitution.
Key specifications for 2B1264: Administration: INTRAVENOUS; Primary Container Content Quantity: 1000.000 MILLILITERS; Primary Container Type: BAG, PLASTIC; Active Medicament Medicinal Strength: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 40.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.